Association between hepatitis B surface antibody seropositivity and coronary artery disease

Alireza Amirzadegan1, Gholamreza Davoodi, Mohammad Ali Boroumand

  • 1Tehran Heart Center, Medical Sciences/University of Tehran, Tehran, Iran.

Insights

Hepatitis B surface antibody seropositivity is not linked to coronary artery disease (CAD). This study found no significant correlation between HBV infection markers and CAD development or C-reactive protein levels.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Epidemiology

Background:

  • Infectious agents are implicated in coronary atherosclerosis pathogenesis.
  • Hepatitis B virus (HBV) infection is prevalent in certain populations.

Purpose of the Study:

  • To assess the association between coronary artery disease (CAD) and hepatitis B surface antibody (HBS Ab) seropositivity.
  • To investigate the relationship between HBS Ab and C-reactive protein (CRP) levels in subjects undergoing coronary angiography.

Main Methods:

  • Cross-sectional study of 830 subjects undergoing coronary angiography.
  • HBS Ab status determined by ELISA; CAD assessed angiographically.
  • Statistical analysis included Chi-square, t-tests, and Pearson's Correlation Coefficient.

Main Results:

  • No significant difference in HBV seropositivity between patients with and without significant CAD (28.7% vs. 28.9%, P=0.954).
  • Mean CRP levels did not differ significantly between HBS Ab positive and negative subjects (10.77 vs. 10.33 mg/L, P=0.465).
  • CRP levels were significantly higher in the CAD group (P<0.001).

Conclusions:

  • Hepatitis B surface antibody seropositivity is not associated with coronary artery disease.
  • No significant linear correlation was found between HBS Ab and CRP levels.
  • CRP levels are elevated in patients with coronary artery disease, independent of HBV status.
Abstract

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...